Related Experiment Video

Updated: May 30, 2026

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia
09:11

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia

Published on: January 23, 2009

The promise of EPC-based therapies on vascular dysfunction in diabetes

Adriana Georgescu1, Nicoleta Alexandru, Andrei Constantinescu

  • 1Petru Poni Institute of Macromolecular Chemistry, Iasi, Romania. adriana.georgescu@icbp.ro

European Journal of Pharmacology
|August 16, 2011
PubMed

Insights

Endothelial progenitor cells (EPCs) show promise for treating vascular dysfunction in diabetes. This cell therapy approach aids in repairing damaged blood vessels, offering a potential cure for diabetes-induced vascular issues.

Area of Science:

  • Cardiovascular Research
  • Metabolic Diseases
  • Regenerative Medicine

Background:

  • Diabetes mellitus is a global metabolic disease characterized by vascular dysfunction.
  • Endothelial cells (ECs) are crucial for vascular health but are impaired in diabetes.
  • Endothelial progenitor cells (EPCs) are key players in repairing damaged endothelium.

Purpose of the Study:

  • To review recent findings on endothelial progenitor cell (EPC) therapy for diabetes-induced vascular dysfunction.
  • To explore the therapeutic potential of EPCs in preventing and curing vascular complications of diabetes.

Main Methods:

  • Review of in vivo and in vitro studies on EPC therapy.
  • Analysis of strategies for utilizing EPCs in cell-based treatments.
  • Assessment of the physiological relevance of proposed EPC-based interventions.

Main Results:

  • EPC therapy demonstrates significant potential in addressing endothelial dysfunction in diabetes.
  • EPCs actively participate in endothelial repair and neovascularization.
  • Therapeutic interventions using EPCs are supported by robust in vivo and in vitro evidence.

Conclusions:

  • EPC therapy is a promising strategy for managing and potentially curing vascular complications associated with diabetes.
  • Cell therapy using EPCs offers a novel approach to restore vascular function in diabetic patients.
  • Further research into EPC-based treatments could revolutionize the care of diabetes-related vascular disease.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...